SCHEMBL17670426

SCHEMBL17670426

O=Cc1cn(Cc2ccc(F)cc2)c(CNCc2cc(C(=O)O)cc(CO)n2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 1/20 0.36
▸ KDM4A O75164 1/20 0.35
▸ KDM5A P29375 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ KDM5B Q9UGL1 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ MMP13 P45452 2/20 0.35
▸ PIK3CA P42336 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ P2RY14 Q15391 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17544589 0.90 PPARA (0.38) ENPP2KDM4AKDM5AKDM4CKDM5B
SCHEMBL17670328 0.84 ALDH1A1 (0.38) KDM4AKDM5AKDM4CKDM5BMAPT
SCHEMBL17544476 0.82 HSP90AA1 (0.43) KDM4AKDM5AKDM4CKDM5BRAB9A
SCHEMBL17545011 0.82 MMP13 (0.37) ENPP2KDM4AKDM5AKDM4CKDM5B
SCHEMBL17670468 0.78 PIK3CA (0.39) MMP13PIK3CAP2RY14AGTR1AGTR2
SCHEMBL17544819 0.78 PDE6D (0.40) KDM4EGAAMAPTMMP13PIK3CA
SCHEMBL17544604 0.78 PDE6D (0.42) MAPTRAB9AMMP13PIK3CAP2RY14
SCHEMBL17545006 0.77 MAPT (0.41) KDM4EMAPTCASP3SENP7POLB
SCHEMBL17544639 0.76 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL17680451 0.76 GNRHR (0.38) ENPP2MAPTMMP13PIK3CAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802941-B2 Compounds and methods for inhibiting histone demethylases GILEAD SCIENCES, INC. (US) 2017-10-31 — — US disclosed
US-9802941-B2 Compounds and methods for inhibiting histone demethylases GILEAD SCIENCES, INC. (US) 2017-10-31 — — US disclosed
US-20160102096-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES EPITHERAPEUTICS APS 2016-04-14 — — US disclosed
US-20160102096-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES EPITHERAPEUTICS APS 2016-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102096-A1 COMPOUNDS AND METHODS FOR INHIBITING HISTONE DEMETHYLASES PHF8, KDM3A, PHF2 ENPP2 3138/4885KDM4A 17/4885KDM5A 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback